<?xml version="1.0" encoding="UTF-8"?>
<!-- This is a template for a FHIR resource, and needs items (marked with "${}") replacing to make a real instance -->
<!-- The resulting instance is a Bundle of Bundles, each of which is a document (having a Composition, and supporting resources) -->
<!-- 2020-02-22 -->
<!-- This is for FHIR version R5 Preview 2 (May 2020) -->
<Bundle xmlns="http://hl7.org/fhir">
	<type value="collection"/>
	<!-- Repeat at this level per document -->
	<entry>
		<fullUrl value="urn:uuid:e70ed86c-e92a-4dc1-ab29-f56758656a93"/>
		<!-- Top level of each document is a also FHIR Bundle, of type "document"
		 see http://hl7.org/fhir/documents.html, http://hl7.org/fhir/bundle.html
	 	 All the other resources for this document are within this. -->
		<resource>
            <Bundle>
            	<!-- When PUTing, some servers mandate an id here to match the existing id -->
            	<id value="70c4c12a-bbc5-4008-a3b4-dfc01d978960"/>
				<!-- document bundles must have an identifier (bdl-9) -->
				<identifier>
					<!-- possibly different identifier types may be needed here -->
					<system value="http://ema.europa.eu/fhir/identifier/documentid"/>
					<value value="${instance.bundle[n].Identifier}"/>
				</identifier>
				<!-- fixed code -->
				<type value="document" /> 
            	<!-- document bundles must have a date (bdl-10) -->
            	<timestamp value="2021-05-19T18:56:04Z"/>
				<!-- a repeating set of entry elements, each with a FHIR resource inside -->
				<entry>
					<!-- fullUrl is mandatory for each entry in document Bundle. It is a random uuid. http://build.fhir.org/bundle.html#bundle-unique -->
					<fullUrl value="urn:uuid:25afa732-ab1e-4b52-9fd0-0158116dcde9"/>
					<resource>
						<!-- the first resource must be Composition (bdl-11) -->
						<!-- This is the overall document structure. -->
						<!-- see definition http://hl7.org/fhir/composition.html, and similar for other resources -->
                        <Composition>
                        	<!-- images if requied within html text of this document -->
							
							<contained>
                                <Binary>
                                	<id value="image0"/>
                                	<!-- example format -->
                                	<contentType value="image/png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="iVBORw0KGgoAAAANSUhEUgAAADUAAAAsCAYAAADFP/AjAAAAAXNSR0IArs4c6QAAAAlwSFlzAAAk6QAAJOkBUCTn+AAAABl0RVh0U29mdHdhcmUATWljcm9zb2Z0IE9mZmljZX/tNXEAAAONSURBVGhD3ZlLSFVRFIatpCgqKho1C4KI6DWsWTWNBg2cZEGTMCroIYU0kAsmFBQSEQ2SrAiEpJHQwGgUEYb0MBpYWUKSWdjLnqT1/bavXNPjOftx8JwWLPa59+691v/ttc++51FeVlb2BZ+D/y/2tRySlfgtfOl/QNUNw+byQqHwsra2toUPe3NesUH0N4tHlZKdwrfiy3NcrV60N0j/CBR0b6jWTg7P4+tyCHYfzVVwvB2FMmDtgKmEebRBgNqLwovLr/j5JAfz8TU5InuIVuketTFQ0LZSrY38ugqfngOwITS2SXcklPnhGu0mfG0OoB6hUXrH2L/LT5vGXap1nF7HMg72AH31pedS1Dk18j0dWwDTeZXlarVK50SraVylSjo941i+LIPLsKhtQmmRUMzCJao1l1FnMwjVIH1RuiarlMY8x1/gWboulCZVKtLioNoYWYOfwxdloGIDZgO76QxFiYfMxe4MglzNANR+NLRIlzOU2QkF1sexAgluqkz5++KAJC5u+RUB7nGwC788VUQmv3TEWiIoZucz1eog2g98VmzU8B2+E7JDOpKETgRlAr2i1Y3khSSBA/fZRzzlT2SJoZilT0RspGIzaU/g8xJl8Oukyhwld6NNmMRQJUF1Xp2xSeLRdzZjrc9jFyjdkhTwQ/hCD8FxQ9/T4TRufQtkDWVO1jqW4YE4VZ6/D5OrziWGNZSSAKRl0YQfdJnJBEKHFV95APuWoP+YLk5QJlE1SacRTQ9sFtsmnqT/O51H5Kh2jekEVUxG4sOArQ8M9VRxXYE0zgvKJO6kXYEv8BFixn6gVTwvCwG1BwVL8C1eSv4Ovo0rnpd5Q7FUhs0F7y/Pymu8Lli1SXiZN5TJrpNam8YOXFcctvaTAVdw582hNGEQKGb3I9U6QmDdHuy2JaJ/E16jOA5jxw0JAqWoCBoArN9RVL/GO45ND8pEvkir/6wqC4F6KaFxwSxYpUy1uqlWl6W6Lqqkl2XBLCiUUaWHNXqesT2BSvVT/6AWHIpZf0y19MhaO5oeAUSZlhzdCz1BiQgWHMoswx7AmmOg9CozOJDypwJlZv417XV82wSV0Pf6PRVLDYoqdFKt+ggova3wvsaLmpHUoExC3QvdwTeUCNBn63skm5KmCkU1nlCtCrMMV9PqJVkF3+tNemqWKpTZNHoBq+T4Bl6ZNlDaG0VpJXTl/Rv3vgJPUt4/q94DKmR3QzEAAAAASUVORK5CYII="/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image0"/>
                        		</valueReference>
               </extension>
              
              
              <contained>
                          <Binary>
                            <id value="stylesheet0"/>
                            <!-- example format -->
                            <contentType value="stylesheet/css"/>
                            <!-- data is base 64 encoded, actual bytes of the image png file -->
                            <data value="<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Consolas;
	panose-1:2 11 6 9 2 2 4 3 2 4;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Calibri",sans-serif;
	text-transform:uppercase;
	font-weight:bold;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
h4
	{mso-style-link:"Heading 4 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
h5
	{mso-style-link:"Heading 5 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
h6
	{mso-style-link:"Heading 6 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-link:"Heading 7 Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-link:"Heading 8 Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	font-style:italic;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-link:"Heading 9 Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;}
p.MsoIndex1, li.MsoIndex1, div.MsoIndex1
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoIndex2, li.MsoIndex2, div.MsoIndex2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:22.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoIndex3, li.MsoIndex3, div.MsoIndex3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:33.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoIndex4, li.MsoIndex4, div.MsoIndex4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:44.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoIndex5, li.MsoIndex5, div.MsoIndex5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:55.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoIndex6, li.MsoIndex6, div.MsoIndex6
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:66.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoIndex7, li.MsoIndex7, div.MsoIndex7
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:77.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoIndex8, li.MsoIndex8, div.MsoIndex8
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:88.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoIndex9, li.MsoIndex9, div.MsoIndex9
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:99.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoToc1, li.MsoToc1, div.MsoToc1
	{margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;
	text-transform:uppercase;}
p.MsoToc2, li.MsoToc2, div.MsoToc2
	{margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;}
p.MsoToc3, li.MsoToc3, div.MsoToc3
	{margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;}
p.MsoToc4, li.MsoToc4, div.MsoToc4
	{margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;}
p.MsoToc5, li.MsoToc5, div.MsoToc5
	{margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;}
p.MsoToc6, li.MsoToc6, div.MsoToc6
	{margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;}
p.MsoToc7, li.MsoToc7, div.MsoToc7
	{margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;}
p.MsoToc8, li.MsoToc8, div.MsoToc8
	{margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;}
p.MsoToc9, li.MsoToc9, div.MsoToc9
	{margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;}
p.MsoNormalIndent, li.MsoNormalIndent, div.MsoNormalIndent
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-link:"Footnote Text Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:10.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-name:"Comment Text\,Comment Text Char Char\,Comment Text Char Char Char Char\,Comment Text Char Char1 Char\,Comment Text Char1 Char Char\,Comment Text Char2 Char";
	mso-style-link:"Comment Text Char\,Comment Text Char Char Char\,Comment Text Char Char Char Char Char\,Comment Text Char Char1 Char Char\,Comment Text Char1 Char Char Char\,Comment Text Char2 Char Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:10.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoIndexHeading, li.MsoIndexHeading, div.MsoIndexHeading
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri Light",sans-serif;
	font-weight:bold;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-name:"Caption\,B Caption\,Bayer Caption\,Caption2\,IB Caption\,Medical Caption\,Table Caption";
	mso-style-link:"Caption Char\,B Caption Char\,Bayer Caption Char\,Caption2 Char\,IB Caption Char\,Medical Caption Char\,Table Caption Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	text-indent:-1.0in;
	line-height:14.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoTof, li.MsoTof, div.MsoTof
	{margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:14.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;}
p.MsoEnvelopeAddress, li.MsoEnvelopeAddress, div.MsoEnvelopeAddress
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;}
p.MsoEnvelopeReturn, li.MsoEnvelopeReturn, div.MsoEnvelopeReturn
	{margin:0in;
	line-height:normal;
	font-size:10.0pt;
	font-family:"Calibri Light",sans-serif;}
span.MsoFootnoteReference
	{vertical-align:super;}
span.MsoEndnoteReference
	{vertical-align:super;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-link:"Endnote Text Char";
	margin:0in;
	line-height:normal;
	font-size:10.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoToa, li.MsoToa, div.MsoToa
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoMacroText, li.MsoMacroText, div.MsoMacroText
	{mso-style-link:"Macro Text Char";
	margin:0in;
	line-height:107%;
	font-size:10.0pt;
	font-family:Consolas;}
p.MsoToaHeading, li.MsoToaHeading, div.MsoToaHeading
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
p.MsoList, li.MsoList, div.MsoList
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListCxSpFirst, li.MsoListCxSpFirst, div.MsoListCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListCxSpMiddle, li.MsoListCxSpMiddle, div.MsoListCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListCxSpLast, li.MsoListCxSpLast, div.MsoListCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet, li.MsoListBullet, div.MsoListBullet
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBulletCxSpFirst, li.MsoListBulletCxSpFirst, div.MsoListBulletCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBulletCxSpMiddle, li.MsoListBulletCxSpMiddle, div.MsoListBulletCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBulletCxSpLast, li.MsoListBulletCxSpLast, div.MsoListBulletCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber, li.MsoListNumber, div.MsoListNumber
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumberCxSpFirst, li.MsoListNumberCxSpFirst, div.MsoListNumberCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumberCxSpMiddle, li.MsoListNumberCxSpMiddle, div.MsoListNumberCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumberCxSpLast, li.MsoListNumberCxSpLast, div.MsoListNumberCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList2, li.MsoList2, div.MsoList2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList2CxSpFirst, li.MsoList2CxSpFirst, div.MsoList2CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList2CxSpMiddle, li.MsoList2CxSpMiddle, div.MsoList2CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList2CxSpLast, li.MsoList2CxSpLast, div.MsoList2CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList3, li.MsoList3, div.MsoList3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList3CxSpFirst, li.MsoList3CxSpFirst, div.MsoList3CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList3CxSpMiddle, li.MsoList3CxSpMiddle, div.MsoList3CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList3CxSpLast, li.MsoList3CxSpLast, div.MsoList3CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList4, li.MsoList4, div.MsoList4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList4CxSpFirst, li.MsoList4CxSpFirst, div.MsoList4CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList4CxSpMiddle, li.MsoList4CxSpMiddle, div.MsoList4CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList4CxSpLast, li.MsoList4CxSpLast, div.MsoList4CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList5, li.MsoList5, div.MsoList5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList5CxSpFirst, li.MsoList5CxSpFirst, div.MsoList5CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList5CxSpMiddle, li.MsoList5CxSpMiddle, div.MsoList5CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoList5CxSpLast, li.MsoList5CxSpLast, div.MsoList5CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet2, li.MsoListBullet2, div.MsoListBullet2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet2CxSpFirst, li.MsoListBullet2CxSpFirst, div.MsoListBullet2CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet2CxSpMiddle, li.MsoListBullet2CxSpMiddle, div.MsoListBullet2CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet2CxSpLast, li.MsoListBullet2CxSpLast, div.MsoListBullet2CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet3, li.MsoListBullet3, div.MsoListBullet3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet3CxSpFirst, li.MsoListBullet3CxSpFirst, div.MsoListBullet3CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet3CxSpMiddle, li.MsoListBullet3CxSpMiddle, div.MsoListBullet3CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet3CxSpLast, li.MsoListBullet3CxSpLast, div.MsoListBullet3CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet4, li.MsoListBullet4, div.MsoListBullet4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet4CxSpFirst, li.MsoListBullet4CxSpFirst, div.MsoListBullet4CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet4CxSpMiddle, li.MsoListBullet4CxSpMiddle, div.MsoListBullet4CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet4CxSpLast, li.MsoListBullet4CxSpLast, div.MsoListBullet4CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet5, li.MsoListBullet5, div.MsoListBullet5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet5CxSpFirst, li.MsoListBullet5CxSpFirst, div.MsoListBullet5CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet5CxSpMiddle, li.MsoListBullet5CxSpMiddle, div.MsoListBullet5CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListBullet5CxSpLast, li.MsoListBullet5CxSpLast, div.MsoListBullet5CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber2, li.MsoListNumber2, div.MsoListNumber2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber2CxSpFirst, li.MsoListNumber2CxSpFirst, div.MsoListNumber2CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber2CxSpMiddle, li.MsoListNumber2CxSpMiddle, div.MsoListNumber2CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber2CxSpLast, li.MsoListNumber2CxSpLast, div.MsoListNumber2CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber3, li.MsoListNumber3, div.MsoListNumber3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber3CxSpFirst, li.MsoListNumber3CxSpFirst, div.MsoListNumber3CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber3CxSpMiddle, li.MsoListNumber3CxSpMiddle, div.MsoListNumber3CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber3CxSpLast, li.MsoListNumber3CxSpLast, div.MsoListNumber3CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber4, li.MsoListNumber4, div.MsoListNumber4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber4CxSpFirst, li.MsoListNumber4CxSpFirst, div.MsoListNumber4CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber4CxSpMiddle, li.MsoListNumber4CxSpMiddle, div.MsoListNumber4CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber4CxSpLast, li.MsoListNumber4CxSpLast, div.MsoListNumber4CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber5, li.MsoListNumber5, div.MsoListNumber5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber5CxSpFirst, li.MsoListNumber5CxSpFirst, div.MsoListNumber5CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber5CxSpMiddle, li.MsoListNumber5CxSpMiddle, div.MsoListNumber5CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListNumber5CxSpLast, li.MsoListNumber5CxSpLast, div.MsoListNumber5CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-link:"Title Char";
	margin:0in;
	line-height:normal;
	font-size:28.0pt;
	font-family:"Calibri Light",sans-serif;
	letter-spacing:-.5pt;}
p.MsoTitleCxSpFirst, li.MsoTitleCxSpFirst, div.MsoTitleCxSpFirst
	{mso-style-link:"Title Char";
	margin:0in;
	line-height:normal;
	font-size:28.0pt;
	font-family:"Calibri Light",sans-serif;
	letter-spacing:-.5pt;}
p.MsoTitleCxSpMiddle, li.MsoTitleCxSpMiddle, div.MsoTitleCxSpMiddle
	{mso-style-link:"Title Char";
	margin:0in;
	line-height:normal;
	font-size:28.0pt;
	font-family:"Calibri Light",sans-serif;
	letter-spacing:-.5pt;}
p.MsoTitleCxSpLast, li.MsoTitleCxSpLast, div.MsoTitleCxSpLast
	{mso-style-link:"Title Char";
	margin:0in;
	line-height:normal;
	font-size:28.0pt;
	font-family:"Calibri Light",sans-serif;
	letter-spacing:-.5pt;}
p.MsoClosing, li.MsoClosing, div.MsoClosing
	{mso-style-link:"Closing Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:3.0in;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoSignature, li.MsoSignature, div.MsoSignature
	{mso-style-link:"Signature Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:3.0in;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-link:"Body Text Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	color:green;
	font-style:italic;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-style-link:"Body Text Indent Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue, li.MsoListContinue, div.MsoListContinue
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinueCxSpFirst, li.MsoListContinueCxSpFirst, div.MsoListContinueCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinueCxSpMiddle, li.MsoListContinueCxSpMiddle, div.MsoListContinueCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinueCxSpLast, li.MsoListContinueCxSpLast, div.MsoListContinueCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue2, li.MsoListContinue2, div.MsoListContinue2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.5in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue2CxSpFirst, li.MsoListContinue2CxSpFirst, div.MsoListContinue2CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue2CxSpMiddle, li.MsoListContinue2CxSpMiddle, div.MsoListContinue2CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue2CxSpLast, li.MsoListContinue2CxSpLast, div.MsoListContinue2CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.5in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue3, li.MsoListContinue3, div.MsoListContinue3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue3CxSpFirst, li.MsoListContinue3CxSpFirst, div.MsoListContinue3CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue3CxSpMiddle, li.MsoListContinue3CxSpMiddle, div.MsoListContinue3CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue3CxSpLast, li.MsoListContinue3CxSpLast, div.MsoListContinue3CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue4, li.MsoListContinue4, div.MsoListContinue4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue4CxSpFirst, li.MsoListContinue4CxSpFirst, div.MsoListContinue4CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue4CxSpMiddle, li.MsoListContinue4CxSpMiddle, div.MsoListContinue4CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue4CxSpLast, li.MsoListContinue4CxSpLast, div.MsoListContinue4CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue5, li.MsoListContinue5, div.MsoListContinue5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue5CxSpFirst, li.MsoListContinue5CxSpFirst, div.MsoListContinue5CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue5CxSpMiddle, li.MsoListContinue5CxSpMiddle, div.MsoListContinue5CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListContinue5CxSpLast, li.MsoListContinue5CxSpLast, div.MsoListContinue5CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoMessageHeader, li.MsoMessageHeader, div.MsoMessageHeader
	{mso-style-link:"Message Header Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	background:#CCCCCC;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-link:"Subtitle Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	color:#5A5A5A;
	letter-spacing:.75pt;}
p.MsoSalutation, li.MsoSalutation, div.MsoSalutation
	{mso-style-link:"Salutation Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoDate, li.MsoDate, div.MsoDate
	{mso-style-link:"Date Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoBodyTextFirstIndent, li.MsoBodyTextFirstIndent, div.MsoBodyTextFirstIndent
	{mso-style-link:"Body Text First Indent Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	text-indent:.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoBodyTextFirstIndent2, li.MsoBodyTextFirstIndent2, div.MsoBodyTextFirstIndent2
	{mso-style-link:"Body Text First Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	text-indent:10.5pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoNoteHeading, li.MsoNoteHeading, div.MsoNoteHeading
	{mso-style-link:"Note Heading Char";
	margin:0in;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{mso-style-link:"Body Text 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:200%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{mso-style-link:"Body Text 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:8.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{mso-style-link:"Body Text Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	line-height:200%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-link:"Body Text Indent 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	line-height:107%;
	font-size:8.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoBlockText, li.MsoBlockText, div.MsoBlockText
	{margin-top:0in;
	margin-right:.8in;
	margin-bottom:8.0pt;
	margin-left:.8in;
	line-height:107%;
	border:none;
	padding:0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	color:#4472C4;
	font-style:italic;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:#954F72;
	text-decoration:underline;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-link:"Document Map Char";
	margin:0in;
	line-height:normal;
	font-size:8.0pt;
	font-family:"Segoe UI",sans-serif;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{mso-style-link:"Plain Text Char";
	margin:0in;
	line-height:normal;
	font-size:10.5pt;
	font-family:Consolas;}
p.MsoAutoSig, li.MsoAutoSig, div.MsoAutoSig
	{mso-style-link:"E-mail Signature Char";
	margin:0in;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p
	{margin-right:0in;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
address
	{mso-style-link:"HTML Address Char";
	margin:0in;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	font-style:italic;}
kbd
	{font-family:"Courier New";}
pre
	{mso-style-link:"HTML Preformatted Char";
	margin:0in;
	line-height:normal;
	font-size:10.0pt;
	font-family:Consolas;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-link:"Comment Subject Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:10.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;}
span.MsoPlaceholderText
	{color:gray;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{margin:0in;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{margin:0in;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoQuote, li.MsoQuote, div.MsoQuote
	{mso-style-link:"Quote Char";
	margin-top:10.0pt;
	margin-right:.6in;
	margin-bottom:8.0pt;
	margin-left:.6in;
	text-align:center;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	color:#404040;
	font-style:italic;}
p.MsoIntenseQuote, li.MsoIntenseQuote, div.MsoIntenseQuote
	{mso-style-link:"Intense Quote Char";
	margin-top:.25in;
	margin-right:.6in;
	margin-bottom:.25in;
	margin-left:.6in;
	text-align:center;
	line-height:107%;
	border:none;
	padding:0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	color:#4472C4;
	font-style:italic;}
p.MsoBibliography, li.MsoBibliography, div.MsoBibliography
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoTocHeading, li.MsoTocHeading, div.MsoTocHeading
	{margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
p.MemoHeaderStyle, li.MemoHeaderStyle, div.MemoHeaderStyle
	{mso-style-name:MemoHeaderStyle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:70.9pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	font-variant:small-caps;
	font-weight:bold;}
p.EMEAEnBodyText, li.EMEAEnBodyText, div.EMEAEnBodyText
	{mso-style-name:"EMEA En Body Text";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:justify;
	text-justify:inter-ideograph;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.BodytextAgency, li.BodytextAgency, div.BodytextAgency
	{mso-style-name:"Body text \(Agency\)";
	mso-style-link:"Body text \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
span.BodytextAgencyChar
	{mso-style-name:"Body text \(Agency\) Char";
	mso-style-link:"Body text \(Agency\)";
	font-family:"Verdana",sans-serif;}
p.DraftingNotesAgency, li.DraftingNotesAgency, div.DraftingNotesAgency
	{mso-style-name:"Drafting Notes \(Agency\)";
	mso-style-link:"Drafting Notes \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:11.0pt;
	font-family:"Courier New";
	color:#339966;
	font-style:italic;}
span.DraftingNotesAgencyChar
	{mso-style-name:"Drafting Notes \(Agency\) Char";
	mso-style-link:"Drafting Notes \(Agency\)";
	font-family:"Courier New";
	color:#339966;
	font-style:italic;}
p.NormalAgency, li.NormalAgency, div.NormalAgency
	{mso-style-name:"Normal \(Agency\)";
	mso-style-link:"Normal \(Agency\) Char";
	margin:0in;
	line-height:normal;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
p.TableheadingrowsAgency, li.TableheadingrowsAgency, div.TableheadingrowsAgency
	{mso-style-name:"Table heading rows \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.TabletextrowsAgency, li.TabletextrowsAgency, div.TabletextrowsAgency
	{mso-style-name:"Table text rows \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
span.NormalAgencyChar
	{mso-style-name:"Normal \(Agency\) Char";
	mso-style-link:"Normal \(Agency\)";
	font-family:"Verdana",sans-serif;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char\,Comment Text Char Char Char\,Comment Text Char Char Char Char Char\,Comment Text Char Char1 Char Char\,Comment Text Char1 Char Char Char\,Comment Text Char2 Char Char";
	mso-style-link:"Comment Text\,Comment Text Char Char\,Comment Text Char Char Char Char\,Comment Text Char Char1 Char\,Comment Text Char1 Char Char\,Comment Text Char2 Char";
	font-family:"Times New Roman",serif;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-link:"Comment Subject";
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.documenttextoutlinenumbered, li.documenttextoutlinenumbered, div.documenttextoutlinenumbered
	{mso-style-name:"document text outline numbered";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.Default, li.Default, div.Default
	{mso-style-name:Default;
	margin:0in;
	line-height:normal;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:black;}
p.C-BodyText, li.C-BodyText, div.C-BodyText
	{mso-style-name:"C-Body Text";
	mso-style-link:"C-Body Text Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.C-BodyTextChar
	{mso-style-name:"C-Body Text Char";
	mso-style-link:"C-Body Text";
	font-family:"Times New Roman",serif;}
span.Mention1
	{mso-style-name:Mention1;
	color:#2B579A;
	background:#E6E6E6;}
p.C-Bullet, li.C-Bullet, div.C-Bullet
	{mso-style-name:C-Bullet;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:14.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.C-BulletIndented, li.C-BulletIndented, div.C-BulletIndented
	{mso-style-name:"C-Bullet Indented";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:14.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.tablefootnote, li.tablefootnote, div.tablefootnote
	{mso-style-name:"table footnote";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:normal;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.CaptionChar
	{mso-style-name:"Caption Char\,B Caption Char\,Bayer Caption Char\,Caption2 Char\,IB Caption Char\,Medical Caption Char\,Table Caption Char";
	mso-style-link:"Caption\,B Caption\,Bayer Caption\,Caption2\,IB Caption\,Medical Caption\,Table Caption";
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.C-Hyperlink
	{mso-style-name:C-Hyperlink;
	color:blue;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-link:"Heading 4";
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Heading5Char
	{mso-style-name:"Heading 5 Char";
	mso-style-link:"Heading 5";
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Heading6Char
	{mso-style-name:"Heading 6 Char";
	mso-style-link:"Heading 6";
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Heading7Char
	{mso-style-name:"Heading 7 Char";
	mso-style-link:"Heading 7";
	font-family:"Times New Roman",serif;}
span.Heading8Char
	{mso-style-name:"Heading 8 Char";
	mso-style-link:"Heading 8";
	font-family:"Times New Roman",serif;
	font-style:italic;}
span.Heading9Char
	{mso-style-name:"Heading 9 Char";
	mso-style-link:"Heading 9";
	font-family:"Arial",sans-serif;}
p.C-Heading1, li.C-Heading1, div.C-Heading1
	{mso-style-name:"C-Heading 1";
	mso-style-link:"C-Heading 1 Char";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-before:always;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.C-Heading2, li.C-Heading2, div.C-Heading2
	{mso-style-name:"C-Heading 2";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.C-Heading3, li.C-Heading3, div.C-Heading3
	{mso-style-name:"C-Heading 3";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.C-Heading4, li.C-Heading4, div.C-Heading4
	{mso-style-name:"C-Heading 4";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.C-Heading5, li.C-Heading5, div.C-Heading5
	{mso-style-name:"C-Heading 5";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.C-Heading6, li.C-Heading6, div.C-Heading6
	{mso-style-name:"C-Heading 6";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.85in;
	text-indent:-.85in;
	line-height:normal;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.C-BodyTextIndent, li.C-BodyTextIndent, div.C-BodyTextIndent
	{mso-style-name:"C-Body Text Indent";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	line-height:14.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.C-TableHeader, li.C-TableHeader, div.C-TableHeader
	{mso-style-name:"C-Table Header";
	margin-top:1.0pt;
	margin-right:0in;
	margin-bottom:1.0pt;
	margin-left:0in;
	line-height:normal;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.C-TableText, li.C-TableText, div.C-TableText
	{mso-style-name:"C-Table Text";
	margin-top:1.0pt;
	margin-right:0in;
	margin-bottom:1.0pt;
	margin-left:0in;
	line-height:normal;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.C-TableFootnote, li.C-TableFootnote, div.C-TableFootnote
	{mso-style-name:"C-Table Footnote";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.1in;
	text-indent:-.1in;
	line-height:normal;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.C-TOCTitle, li.C-TOCTitle, div.C-TOCTitle
	{mso-style-name:"C-TOC Title";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:normal;
	font-size:14.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.C-CaptionContinued, li.C-CaptionContinued, div.C-CaptionContinued
	{mso-style-name:"C-Caption Continued";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	text-indent:-1.0in;
	line-height:14.0pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.C-NumberedList, li.C-NumberedList, div.C-NumberedList
	{mso-style-name:"C-Numbered List";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:14.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.C-InstructionText, li.C-InstructionText, div.C-InstructionText
	{mso-style-name:"C-Instruction Text";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:red;
	display:none;}
p.C-Title, li.C-Title, div.C-Title
	{mso-style-name:C-Title;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:normal;
	font-size:18.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.C-Header, li.C-Header, div.C-Header
	{mso-style-name:C-Header;
	margin:0in;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.C-Footer, li.C-Footer, div.C-Footer
	{mso-style-name:C-Footer;
	margin:0in;
	text-align:right;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.C-Heading1non-numbered, li.C-Heading1non-numbered, div.C-Heading1non-numbered
	{mso-style-name:"C-Heading 1 \(non-numbered\)";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-before:always;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.C-Heading2non-numbered, li.C-Heading2non-numbered, div.C-Heading2non-numbered
	{mso-style-name:"C-Heading 2 \(non-numbered\)";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.C-Heading3non-numbered, li.C-Heading3non-numbered, div.C-Heading3non-numbered
	{mso-style-name:"C-Heading 3 \(non-numbered\)";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.C-Heading4non-numbered, li.C-Heading4non-numbered, div.C-Heading4non-numbered
	{mso-style-name:"C-Heading 4 \(non-numbered\)";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.C-Heading5non-numbered, li.C-Heading5non-numbered, div.C-Heading5non-numbered
	{mso-style-name:"C-Heading 5 \(non-numbered\)";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.C-Heading6non-numbered, li.C-Heading6non-numbered, div.C-Heading6non-numbered
	{mso-style-name:"C-Heading 6 \(non-numbered\)";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.C-Heading1nopagebreak, li.C-Heading1nopagebreak, div.C-Heading1nopagebreak
	{mso-style-name:"C-Heading 1 \(no page break\)";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.C-Heading1nopagebreak0, li.C-Heading1nopagebreak0, div.C-Heading1nopagebreak0
	{mso-style-name:"C-Heading 1 \(no page break\,non-numbered\)";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.C-AlphabeticList, li.C-AlphabeticList, div.C-AlphabeticList
	{mso-style-name:"C-Alphabetic List";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:normal;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.C-Appendix, li.C-Appendix, div.C-Appendix
	{mso-style-name:C-Appendix;
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:99.35pt;
	text-indent:-99.35pt;
	line-height:normal;
	page-break-before:always;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
span.C-TableCallout
	{mso-style-name:"C-Table Callout";
	font-family:"Times New Roman",serif;
	color:windowtext;
	position:relative;
	top:.5pt;
	letter-spacing:0pt;
	text-decoration:none none;
	vertical-align:super;}
span.BodyTextIndentChar
	{mso-style-name:"Body Text Indent Char";
	mso-style-link:"Body Text Indent";
	font-family:"Times New Roman",serif;}
span.BodyTextFirstIndent2Char
	{mso-style-name:"Body Text First Indent 2 Char";
	mso-style-link:"Body Text First Indent 2";
	font-family:"Times New Roman",serif;}
p.C-AppendixNumbered, li.C-AppendixNumbered, div.C-AppendixNumbered
	{mso-style-name:"C-Appendix \(Numbered\)";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:99.35pt;
	text-indent:-99.35pt;
	line-height:normal;
	page-break-before:always;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.C-Alphabetic, li.C-Alphabetic, div.C-Alphabetic
	{mso-style-name:C-Alphabetic;
	mso-style-link:"C-Alphabetic Char";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-before:always;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.C-Footnote, li.C-Footnote, div.C-Footnote
	{mso-style-name:C-Footnote;
	margin:0in;
	line-height:normal;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.C-Heading1Char
	{mso-style-name:"C-Heading 1 Char";
	mso-style-link:"C-Heading 1";
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
span.C-AlphabeticChar
	{mso-style-name:"C-Alphabetic Char";
	mso-style-link:C-Alphabetic;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;
	font-family:"Times New Roman",serif;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;
	font-family:"Times New Roman",serif;}
span.normaltextrun
	{mso-style-name:normaltextrun;}
span.spellingerror
	{mso-style-name:spellingerror;}
p.DisclaimerAgency, li.DisclaimerAgency, div.DisclaimerAgency
	{mso-style-name:"Disclaimer \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:2.85pt;
	margin-left:0in;
	line-height:7.5pt;
	font-size:6.5pt;
	font-family:"Verdana",sans-serif;
	color:#6D6F71;
	layout-grid-mode:line;}
p.DoccategoryheadingAgency, li.DoccategoryheadingAgency, div.DoccategoryheadingAgency
	{mso-style-name:"Doc category heading \(Agency\)";
	margin-top:28.35pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	line-height:normal;
	page-break-after:avoid;
	border:none;
	padding:0in;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	color:#003399;
	font-weight:bold;}
p.DocsubtitleAgency, li.DocsubtitleAgency, div.DocsubtitleAgency
	{mso-style-name:"Doc subtitle \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:32.0pt;
	margin-left:0in;
	line-height:18.0pt;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;}
p.DoctitleAgency, li.DoctitleAgency, div.DoctitleAgency
	{mso-style-name:"Doc title \(Agency\)";
	margin-top:.5in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:18.0pt;
	font-size:16.0pt;
	font-family:"Verdana",sans-serif;
	color:#003399;}
span.EndnotereferenceAgency
	{mso-style-name:"Endnote reference \(Agency\)";
	font-family:"Verdana",sans-serif;
	vertical-align:super;}
p.EndnotetextAgency, li.EndnotetextAgency, div.EndnotetextAgency
	{mso-style-name:"Endnote text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:7.5pt;
	font-family:"Verdana",sans-serif;}
p.FigureAgency, li.FigureAgency, div.FigureAgency
	{mso-style-name:"Figure \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	text-align:center;
	line-height:107%;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
p.FigureheadingAgency, li.FigureheadingAgency, div.FigureheadingAgency
	{mso-style-name:"Figure heading \(Agency\)";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.3in;
	text-indent:-.3in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
p.FooterAgency, li.FooterAgency, div.FooterAgency
	{mso-style-name:"Footer \(Agency\)";
	mso-style-link:"Footer \(Agency\) Char Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:7.0pt;
	font-family:"Verdana",sans-serif;
	color:#6D6F71;}
span.FooterAgencyCharChar
	{mso-style-name:"Footer \(Agency\) Char Char";
	mso-style-link:"Footer \(Agency\)";
	font-family:"Verdana",sans-serif;
	color:#6D6F71;}
p.FooterblueAgency, li.FooterblueAgency, div.FooterblueAgency
	{mso-style-name:"Footer blue \(Agency\)";
	mso-style-link:"Footer blue \(Agency\) Char Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:6.5pt;
	font-family:"Verdana",sans-serif;
	color:#003399;
	font-weight:bold;}
span.FooterblueAgencyCharChar
	{mso-style-name:"Footer blue \(Agency\) Char Char";
	mso-style-link:"Footer blue \(Agency\)";
	font-family:"Verdana",sans-serif;
	color:#003399;
	font-weight:bold;}
span.FootnotereferenceAgency
	{mso-style-name:"Footnote reference \(Agency\)";
	font-family:"Verdana",sans-serif;
	color:windowtext;
	vertical-align:super;}
p.FootnotetextAgency, li.FootnotetextAgency, div.FootnotetextAgency
	{mso-style-name:"Footnote text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:7.5pt;
	font-family:"Verdana",sans-serif;}
p.HeaderAgency, li.HeaderAgency, div.HeaderAgency
	{mso-style-name:"Header \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:7.0pt;
	font-family:"Verdana",sans-serif;
	color:#6D6F71;}
p.Heading1Agency, li.Heading1Agency, div.Heading1Agency
	{mso-style-name:"Heading 1 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:13.5pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.Heading2Agency, li.Heading2Agency, div.Heading2Agency
	{mso-style-name:"Heading 2 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;
	font-style:italic;}
p.Heading3Agency, li.Heading3Agency, div.Heading3Agency
	{mso-style-name:"Heading 3 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.Heading4Agency, li.Heading4Agency, div.Heading4Agency
	{mso-style-name:"Heading 4 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;
	font-style:italic;}
p.Heading5Agency, li.Heading5Agency, div.Heading5Agency
	{mso-style-name:"Heading 5 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.Heading6Agency, li.Heading6Agency, div.Heading6Agency
	{mso-style-name:"Heading 6 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.Heading7Agency, li.Heading7Agency, div.Heading7Agency
	{mso-style-name:"Heading 7 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.Heading8Agency, li.Heading8Agency, div.Heading8Agency
	{mso-style-name:"Heading 8 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.Heading9Agency, li.Heading9Agency, div.Heading9Agency
	{mso-style-name:"Heading 9 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.No-numheading1Agency, li.No-numheading1Agency, div.No-numheading1Agency
	{mso-style-name:"No-num heading 1 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:13.5pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.HeadingcentredAgency, li.HeadingcentredAgency, div.HeadingcentredAgency
	{mso-style-name:"Heading centred \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-align:center;
	line-height:107%;
	page-break-after:avoid;
	font-size:13.5pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.No-numheading2Agency, li.No-numheading2Agency, div.No-numheading2Agency
	{mso-style-name:"No-num heading 2 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;
	font-style:italic;}
p.No-numheading3Agency, li.No-numheading3Agency, div.No-numheading3Agency
	{mso-style-name:"No-num heading 3 \(Agency\)";
	mso-style-link:"No-num heading 3 \(Agency\) Char";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.No-numheading4Agency, li.No-numheading4Agency, div.No-numheading4Agency
	{mso-style-name:"No-num heading 4 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;
	font-style:italic;}
p.No-numheading5Agency, li.No-numheading5Agency, div.No-numheading5Agency
	{mso-style-name:"No-num heading 5 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.No-numheading6Agency, li.No-numheading6Agency, div.No-numheading6Agency
	{mso-style-name:"No-num heading 6 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.No-numheading7Agency, li.No-numheading7Agency, div.No-numheading7Agency
	{mso-style-name:"No-num heading 7 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.No-numheading8Agency, li.No-numheading8Agency, div.No-numheading8Agency
	{mso-style-name:"No-num heading 8 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.No-numheading9Agency, li.No-numheading9Agency, div.No-numheading9Agency
	{mso-style-name:"No-num heading 9 \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.No-TOCheadingAgency, li.No-TOCheadingAgency, div.No-TOCheadingAgency
	{mso-style-name:"No-TOC heading \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:13.5pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.PagenumberAgency, li.PagenumberAgency, div.PagenumberAgency
	{mso-style-name:"Page number \(Agency\)";
	mso-style-link:"Page number \(Agency\) Char Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	text-align:right;
	line-height:107%;
	font-size:7.0pt;
	font-family:"Verdana",sans-serif;
	color:#6D6F71;}
span.PagenumberAgencyCharChar
	{mso-style-name:"Page number \(Agency\) Char Char";
	mso-style-link:"Page number \(Agency\)";
	font-family:"Verdana",sans-serif;
	color:#6D6F71;}
p.RefAgency, li.RefAgency, div.RefAgency
	{mso-style-name:"Ref\. \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:8.5pt;
	font-family:"Verdana",sans-serif;}
p.SpecialcommentAgency, li.SpecialcommentAgency, div.SpecialcommentAgency
	{mso-style-name:"Special comment \(Agency\)";
	margin:0in;
	line-height:normal;
	font-size:8.5pt;
	font-family:"Verdana",sans-serif;
	color:red;}
p.TablefirstrowAgency, li.TablefirstrowAgency, div.TablefirstrowAgency
	{mso-style-name:"Table first row \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.TableheadingAgency, li.TableheadingAgency, div.TableheadingAgency
	{mso-style-name:"Table heading \(Agency\)";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
p.TableFigurenoteAgency, li.TableFigurenoteAgency, div.TableFigurenoteAgency
	{mso-style-name:"Table\/Figure note \(Agency\)";
	margin-top:3.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	line-height:normal;
	font-size:8.0pt;
	font-family:"Verdana",sans-serif;}
span.FootnoteTextChar
	{mso-style-name:"Footnote Text Char";
	mso-style-link:"Footnote Text";
	font-family:"Calibri",sans-serif;}
span.UnresolvedMention1
	{mso-style-name:"Unresolved Mention1";
	color:#605E5C;
	background:#E1DFDD;}
span.No-numheading3AgencyChar
	{mso-style-name:"No-num heading 3 \(Agency\) Char";
	mso-style-link:"No-num heading 3 \(Agency\)";
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
span.EndnoteTextChar
	{mso-style-name:"Endnote Text Char";
	mso-style-link:"Endnote Text";
	font-family:"Calibri",sans-serif;}
span.UnresolvedMention2
	{mso-style-name:"Unresolved Mention2";
	color:#605E5C;
	background:#E1DFDD;}
span.Mention2
	{mso-style-name:Mention2;
	color:#2B579A;
	background:#E1DFDD;}
span.BodyText2Char
	{mso-style-name:"Body Text 2 Char";
	mso-style-link:"Body Text 2";
	font-family:"Calibri",sans-serif;}
span.BodyText3Char
	{mso-style-name:"Body Text 3 Char";
	mso-style-link:"Body Text 3";
	font-family:"Calibri",sans-serif;}
span.BodyTextChar
	{mso-style-name:"Body Text Char";
	mso-style-link:"Body Text";
	font-family:"Calibri",sans-serif;
	color:green;
	font-style:italic;}
span.BodyTextFirstIndentChar
	{mso-style-name:"Body Text First Indent Char";
	mso-style-link:"Body Text First Indent";
	font-family:"Calibri",sans-serif;
	color:green;
	font-style:normal;}
span.BodyTextIndent2Char
	{mso-style-name:"Body Text Indent 2 Char";
	mso-style-link:"Body Text Indent 2";
	font-family:"Calibri",sans-serif;}
span.BodyTextIndent3Char
	{mso-style-name:"Body Text Indent 3 Char";
	mso-style-link:"Body Text Indent 3";
	font-family:"Calibri",sans-serif;}
span.ClosingChar
	{mso-style-name:"Closing Char";
	mso-style-link:Closing;
	font-family:"Calibri",sans-serif;}
span.DateChar
	{mso-style-name:"Date Char";
	mso-style-link:Date;
	font-family:"Calibri",sans-serif;}
span.DocumentMapChar
	{mso-style-name:"Document Map Char";
	mso-style-link:"Document Map";
	font-family:"Segoe UI",sans-serif;}
span.E-mailSignatureChar
	{mso-style-name:"E-mail Signature Char";
	mso-style-link:"E-mail Signature";
	font-family:"Calibri",sans-serif;}
span.HTMLAddressChar
	{mso-style-name:"HTML Address Char";
	mso-style-link:"HTML Address";
	font-family:"Calibri",sans-serif;
	font-style:italic;}
span.HTMLPreformattedChar
	{mso-style-name:"HTML Preformatted Char";
	mso-style-link:"HTML Preformatted";
	font-family:Consolas;}
span.IntenseQuoteChar
	{mso-style-name:"Intense Quote Char";
	mso-style-link:"Intense Quote";
	font-family:"Calibri",sans-serif;
	color:#4472C4;
	font-style:italic;}
span.MacroTextChar
	{mso-style-name:"Macro Text Char";
	mso-style-link:"Macro Text";
	font-family:Consolas;}
span.MessageHeaderChar
	{mso-style-name:"Message Header Char";
	mso-style-link:"Message Header";
	font-family:"Calibri Light",sans-serif;
	background:#CCCCCC;}
span.NoteHeadingChar
	{mso-style-name:"Note Heading Char";
	mso-style-link:"Note Heading";
	font-family:"Calibri",sans-serif;}
span.PlainTextChar
	{mso-style-name:"Plain Text Char";
	mso-style-link:"Plain Text";
	font-family:Consolas;}
span.QuoteChar
	{mso-style-name:"Quote Char";
	mso-style-link:Quote;
	font-family:"Calibri",sans-serif;
	color:#404040;
	font-style:italic;}
span.SalutationChar
	{mso-style-name:"Salutation Char";
	mso-style-link:Salutation;
	font-family:"Calibri",sans-serif;}
span.SignatureChar
	{mso-style-name:"Signature Char";
	mso-style-link:Signature;
	font-family:"Calibri",sans-serif;}
span.SubtitleChar
	{mso-style-name:"Subtitle Char";
	mso-style-link:Subtitle;
	font-family:"Calibri",sans-serif;
	color:#5A5A5A;
	letter-spacing:.75pt;}
span.TitleChar
	{mso-style-name:"Title Char";
	mso-style-link:Title;
	font-family:"Calibri Light",sans-serif;
	letter-spacing:-.5pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:595.35pt 842.0pt;
	margin:56.9pt 70.55pt 56.9pt 70.55pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>"/>
                          </Binary>
                        </contained>
                        <!-- this exension is necessary per image -->
                        <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                          <valueReference>
                            <reference value="#stylesheet0"/>
                          </valueReference>
                        </extension>
              
              <status value="final"/>
							<!-- document type -->
							<type>
								<coding>
									<system value="http://spor.ema.europa.eu/v1/lists/100000155531"/>
									<code value="${document[n].documentTypeCode}"/>
									<display value="${document[n].documentTypeDisplay}"/>
								</coding>
							</type>
							<subject>
								<!-- links to the List resource in this bundle - local url format -->
								<reference value="[]"/> <!-- local url format -->
								<!--reference value="${instance.bundle[n].listUuid}"/--> <!-- uuid url format. Possible alternate format may be neeed -->
							</subject>
                        	<!-- mandatory date of the document -->
                        	<date value="2021-02-01"/>
							<author>
								<identifier>
									<system value="http://spor.ema.europa.eu/v1/locations" />
									<value value="" />
								</identifier>
							</author>
                        	<title value="${document[n].title}"/>
							<relatesTo>
								<code value="appends"/>
								<targetReference>
									<!-- reference to another Composition -->
									<reference value="${document[n].relatesTo}"/>
								</targetReference>
							</relatesTo>
							<!-- main sections of the document, to follow the QRD template -->
	               			
<section>
	
		
			<title value="B. PACKAGE LEAFLET"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <span style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p align="center" class="MsoNormal" style="margin-bottom:0in;text-align:center; line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Package leaflet: Information for the patient or carer</span></b></p><p align="center" class="MsoNormal" style="margin-bottom:0in;text-align:center; line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Zynteglo 1.220  10<sup>6 </sup>cells/mL dispersion for infusion</span></b></p><p align="center" class="MsoNormal" style="margin-bottom:0in;text-align:center; line-height:normal"><span style='font-family:"Times New Roman",serif'>betibeglogene autotemcel </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span lang="EN-GB" style='font-family:"Times New Roman",serif'><img alt="BT_1000x858px" border="0" height="18" id="Picture 1882439266" src="#image0" width="21"/></span><span style='font-family:"Times New Roman",serif'>This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Read all of this leaflet carefully before you are given this medicine because it contains important information for you.</span></b></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal;text-autospace: none"><span style='font-family:"Times New Roman",serif'>You will be given a <b>Patient Alert Card</b> which contains important safety information that you need to know about your treatment with Zynteglo. You should carry the Patient Alert Card with you at all times and show it to your doctor or nurse when you see them or if you are admitted to the hospital.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:.25in;text-indent:-.25in;line-height:normal"><span style='font-family:"Times New Roman",serif'>-</span><span style='font-family:"Times New Roman",serif'>Keep this leaflet. You may need to read it again. </span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:.25in;text-indent:-.25in;line-height:normal"><span style='font-family:"Times New Roman",serif'>-</span><span style='font-family:"Times New Roman",serif'>If you have any further questions, ask your doctor or nurse.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in; margin-left:.25in;text-indent:-.25in;line-height:normal"><span style='font-family:"Times New Roman",serif'>-</span><span style='font-family:"Times New Roman",serif'>If you get any side effects, talk to your doctor or nurse.This includes any possible side effects not listed in this leaflet. See section 4.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in; margin-left:.25in;text-indent:-.25in;line-height:normal"><span style='font-family:"Times New Roman",serif'>-</span><span style='font-family:"Times New Roman",serif'>Read the Patient Alert Card carefully and follow the instructions on it. </span></p><p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in; margin-left:.25in;line-height:normal"></p>
			</div>
		</text>
		
		
    	    
				
			    
						
		               
<section>
			<title value="What is in this leaflet"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>1.     What Zynteglo is and what it is used for </span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>2.     What you need to know before you are given Zynteglo</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>3.     How Zynteglo is given</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>4.     Possible side effects </span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>5.     How to store Zynteglo </span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>6.     Contents of the pack and other information</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="1.       What Zynteglo is and what it is used for"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Zynteglo</span><span style='font-family:"Times New Roman",serif'> is used to treat a serious genetic disease called transfusiondependent betathalassaemia (TDT), which includes the disease commonly known as betathalassaemia major, in people 12 years and older. People with this condition cannot make enough haemoglobin, a protein in the blood that carries oxygen. More specifically, people with TDT do not make enough of a part of the haemoglobin called beta-globin, due to a gene defect. Because of this defect, people with TDT are anaemic and need frequent blood transfusions to survive.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Zynteglo is a type of medicine called gene therapy. It is made specifically for each patient, using the patients own (also called autologous) blood stem cells. Zynteglo works by adding functional copies of the beta-globin gene into these cells, so that the patient can make enough beta-globin to increase total haemoglobin, improve anaemia, and carry more oxygen around their body. This reduces or eliminates the need for blood transfusions.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="2.       What you need to know before you are given Zynteglo"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>You must not be given Zynteglo if you</span></b><span style='font-family:"Times New Roman",serif'>:</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in; margin-left:.25in;text-indent:-.25in;line-height:normal"><span style='font-family:"Times New Roman",serif'>-</span><span style='font-family:"Times New Roman",serif'>are allergic to any of the ingredients of this medicine (listed in section 6)</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in; margin-left:.25in;text-indent:-.25in;line-height:normal"><span style='font-family:"Times New Roman",serif'>-</span><span style='font-family:"Times New Roman",serif'>are pregnant or breast-feeding</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in; margin-left:.25in;text-indent:-.25in;line-height:normal"><a name="_Hlk817587"><span style='font-family:"Times New Roman",serif'>-</span><span style='font-family:"Times New Roman",serif'>have previously received gene therapy of your blood stem cells</span></a></p><p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-bottom:0in; margin-left:.25in;text-indent:-.25in;line-height:normal"><span style='font-family:"Times New Roman",serif'>-</span><span style='font-family:"Times New Roman",serif'>are allergic to any of the ingredients in the medicines you will be given for mobilisation and chemotherapy (see section 3).</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Warnings and precautions "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Talk to your doctor before you are given Zynteglo.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="C-BodyText" style="margin:0in;line-height:normal"><span style="font-size:11.0pt">Before treatment with Zynteglo, you will be given medicines know as mobilisation medicine and chemotherapy medicine (see sections 3 and 4 for more information on these medicines, including possible side effects).</span></p><p class="C-BodyText" style="margin:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Before treatment with Zynteglo, your doctor will perform tests to make sure your heart and liver are functioning properly so you can be treated safely with Zynteglo. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Zynteglo</span><span style='font-family:"Times New Roman",serif'> is made specifically for you, using your own blood stem cells. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>After you have been treated with Zynteglo, you will not be able to donate blood, organs, or tissues in the future. This is because Zynteglo is a gene therapy medicine. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Adding a new gene into the DNA of your blood stem cells could theoretically cause leukaemia or lymphoma, although no patients have developed leukaemia or lymphoma in clinical trials with Zynteglo. After treatment with Zynteglo, you will be asked to enrol in a registry for at least 15 years in order to better understand the long-term effects of Zynteglo. During the long-term follow-up, your doctor will monitor you for any signs of leukaemia or lymphoma. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Zynteglo is prepared using parts of the human immunodeficiency virus (HIV), which have been altered so that they cannot cause HIV infection. The modified virus is used to insert a functional beta-globin gene into your blood stem cells. Although this medicine will not give you HIV infection, having Zynteglo in your blood may cause a false positive HIV test result with some commercial tests that recognise a piece of HIV used to make Zynteglo. If you test positive for HIV following treatment, please contact your doctor or nurse. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Before receiving Zynteglo you will be given chemotherapy in order to remove your existing bone marrow. If Zynteglo cannot be administered after chemotherapy or if the modified stem cells do not take hold (engraft) in your body, the doctor may give you an infusion of your own original blood stem cells that were collected and stored before the treatment started (see also section 3, How Zynteglo is given)<i>. </i></span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>After you receive Zynteglo, you may have a low number of platelets in your blood. This means that your blood may not be able to clot as well as normal and you may be prone to bleeding. You must get medical attention if you: </span></p><p class="MsoListParagraph" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>bump your head or have a head injury</span></p><p class="MsoListParagraph" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>have symptoms that could be from internal bleeding, such as unusual stomach or back pain, or severe headache</span></p><p class="MsoListParagraph" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>have abnormal bruising or bleeding (such as bruising without injury, blood in your urine, stool, vomit, or cough up blood).</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Your doctor will tell you when your platelet count has recovered to normal levels.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Other medicines and Zynteglo "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Tell your doctor if you are taking, have recently taken or might take any other medicines.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>You should not take hydroxyurea (a medicine for blood disorders) or any medicines for HIV infection from at least one month before you undergo mobilisation until at least 7 days after Zynteglo infusion (see also section 3, How Zynteglo is given).</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>You should stop taking medicines to remove iron from your body (so-called chelating agents: deferoxamine, deferiprone and/or deferasirox) 7 days before you start the chemotherapy before the infusion of Zynteglo (see section 3, How Zynteglo is given). Your doctor will advise you if and when you should start taking these medicines after Zynteglo infusion. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Talk to your doctor if you need to have any vaccinations. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Pregnancy, breast-feeding and fertility"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, tell your doctor before you are given this medicine.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>If you are a woman, you will be given a pregnancy test before starting mobilisation, before you are given chemotherapy, and before Zynteglo treatment in order to confirm that you are not pregnant.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Women who could become pregnant and men capable of fathering a child must start using a reliable method of contraception from before their blood stem cells are collected and continue until at least 6 months after receiving Zynteglo.  Reliable methods of contraception include intra-uterine device or a combination of oral contraceptive (also know as the pill) and condoms.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>The added gene from Zynteglo will not be passed on to your children. Your children are still at risk of inheriting your original betaglobin gene.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>You should not be given Zynteglo if you are breast-feeding. It is not known whether the ingredients of Zynteglo can pass into breast milk.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>It may no longer be possible for you to become pregnant or father a child after receiving chemotherapy medicine. If you are concerned about having children, you should discuss this with your doctor before treatment. Options may include providing reproductive material for storage in a tissue bank to use at a later time. For men, this may be sperm or testicular tissue. For women, this may be eggs (oocytes) or ovarian tissue.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Driving and using machines"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><a name="_Hlk32575891"><span style='font-family:"Times New Roman",serif'>Zynteglo has no influence on the ability to drive or use machines. However, the mobilisation and chemotherapy medicines may cause dizziness and fatigue. Avoid driving or using machines if you feel dizzy, tired or unwell.</span></a></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Sodium content</span></b></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>This medicine contains 3911564 mg sodium (main component of cooking/table salt) in each dose. This is equivalent to <span style="color: black">2078% </span>of the recommended maximum daily dietary intake of sodium for an adult.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal;page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>3.</span></b><b><span style='font-family:"Times New Roman",serif'>       How Zynteglo is given</span></b></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Zynteglo is given by a drip (infusion) into a vein. It can only be given in a specialised hospital by doctors who are experienced in treating patients with TDT, administering bone marrow transplants, and using gene therapy medicines.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Zynteglo can only be made if enough of the right kind of blood stem cells can be collected from your blood (CD34<sup>+</sup> blood stem cells). Approximately 2 months before treatment with Zynteglo, you will be given a mobilisation medicine that will move your blood stem cells from your bone marrow into your blood stream. The blood stem cells can then be collected by a machine that separates blood components (apheresis machine). It may take more than 1 day to collect enough blood stem cells to make Zynteglo and to store as replacement cells if Zynteglo cannot be given or does not work.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <thead> <tr> <td style="width:151.25pt;border:solid windowtext 1.0pt;    padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:    0in;margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Time</span></b></p> </td> <td style="width:151.25pt;border:solid windowtext 1.0pt;    border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:    0in;margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>What    happens</span></b></p> </td> <td style="width:151.25pt;border:solid windowtext 1.0pt;    border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:    0in;margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Why</span></b></p> </td> </tr> </thead> <tr> <td style="width:151.25pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:   0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Approximately   2 months before Zynteglo infusion</span></p> </td> <td style="width:151.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:   0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Mobilisation   medicine is given</span></p> </td> <td style="width:151.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:   0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>To   move the blood stem cells from your bone marrow into your blood stream.</span></p> </td> </tr> <tr> <td style="width:151.25pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:   0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Approximately   2 months before Zynteglo infusion</span></p> </td> <td style="width:151.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:   0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Blood   stem cells are collected </span></p> </td> <td style="width:151.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:   0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>To   make Zynteglo and to serve as replacement cells if needed.</span></p> </td> </tr> <tr> <td style="width:151.25pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:   0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>At   least 6 days before Zynteglo infusion</span></p> </td> <td style="width:151.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:   0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>A   chemotherapy medicine is given for 4 days in a hospital</span></p> </td> <td style="width:151.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:   0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>To   prepare your bone marrow for treatment with Zynteglo.</span></p> </td> </tr> <tr style="page-break-inside:avoid"> <td style="width:151.25pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:   0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Start   of Zynteglo treatment</span></p> </td> <td style="width:151.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:   0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Zynteglo   is given by a drip (infusion) into a vein. This will take place in a hospital   and will take less than 30 minutes for each infusion bag. The number of bags   will vary by patient.</span></p> </td> <td style="width:151.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:   0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>To   add blood stem cells containing functional copies of the beta-globin into   your bone marrow.</span></p> </td> </tr> <tr> <td style="width:151.25pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal;page-break-after:   avoid"><span style='font-family:"Times New Roman",serif'>After Zynteglo   infusion</span></p> </td> <td style="width:151.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal;page-break-after:   avoid"><span style='font-family:"Times New Roman",serif'>You will remain in   the hospital for approximately 36 weeks</span></p> </td> <td style="width:151.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="202"> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal;page-break-after:   avoid"><span style='font-family:"Times New Roman",serif'>To recover and be monitored   until your doctor is satisfied that it is safe for you to leave the hospital.</span></p> </td> </tr> </table><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:28.35pt;text-indent:-28.35pt;line-height:normal"><a name="_Hlk512253721"></a></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:28.35pt;text-indent:-28.35pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="4.       Possible side effects"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:28.35pt;text-indent:-28.35pt;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Like all medicines, this medicine can cause side effects, although not everybody gets them. </span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Some side effects observed in clinical studies with Zynteglo are related to mobilisation and blood stem cell collection or to the chemotherapy medicine used to prepare your bone marrow for treatment with Zynteglo. </span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>You should discuss possible side effects due to the mobilisation medicines and chemotherapy medicine with your doctor. You should also read the package leaflets for these medicines.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><b><u><span style='font-family:"Times New Roman",serif'>Mobilisation and blood stem cell collection</span></u></b></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Most of these side effects occur during or within a few days after mobilisation and blood stem cell collection but can occur later. Tell your doctor immediately if side effects become severe or serious. </span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Very common side effects </span></b><span style='font-family:"Times New Roman",serif'>(may affect more than 1 in 10 people)</span></p><ul style="margin-top:0in" type="disc"> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><a name="_Hlk542621"><span style='font-family:"Times New Roman",serif'>a      low level of blood platelets, which may reduce the ability of blood to      clot</span></a></li> </ul><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><a name="_Hlk542621"><span style='font-family:"Times New Roman",serif'>a      low level of blood platelets, which may reduce the ability of blood to      clot</span></a></li><a name="_Hlk542621"><span style='font-family:"Times New Roman",serif'>a      low level of blood platelets, which may reduce the ability of blood to      clot</span></a><span style='font-family:"Times New Roman",serif'>a      low level of blood platelets, which may reduce the ability of blood to      clot</span><p class="MsoListParagraph" style="margin-top:0in;margin-right:-1.45pt; margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>bone pain</span></p><ul style="margin-top:0in" type="disc"> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>numbness and      pain in hands and feet</span></li> </ul><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>numbness and      pain in hands and feet</span></li><span style='font-family:"Times New Roman",serif'>numbness and      pain in hands and feet</span><p class="MsoListParagraph" style="margin-top:0in;margin-right:-1.45pt; margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>feeling sick (nausea)</span></p><ul style="margin-top:0in" type="disc"> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>headache</span></li> </ul><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>headache</span></li><span style='font-family:"Times New Roman",serif'>headache</span><p class="MsoListParagraph" style="margin-top:0in;margin-right:-1.45pt; margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>low blood calcium level</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Common side effects </span></b><span style='font-family:"Times New Roman",serif'>(may affect up to 1 in 10 people)</span></p><p class="MsoListParagraphCxSpFirst" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><a name="_Hlk540035"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>bleeding </span></a></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>low oxygen level in blood </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>low blood pressure</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>abdominal pain</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>back pain</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>bone or muscle pain</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>chest pain or discomfort</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>other pain</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>agitation </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>abnormal blood test results (decrease in magnesium and potassium, too much citrate, or increase in white blood cells)</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>abnormal heart rhythm </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>bruising, bleeding or pain from catheter or injection site</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>injection site reaction </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>bruising  </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>dizziness, tiredness</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>head discomfort</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>excessive sweating</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>flu like illness</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>lip swelling</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>tingling or numbness of the hands, feet, or mouth</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>fever</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>rash</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>enlarged spleen which may result in pain in your upper left belly or left shoulder</span></p><p class="MsoListParagraphCxSpLast" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>vomiting </span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><b><u><span style='font-family:"Times New Roman",serif'></span></u></b></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><b><u><span style='font-family:"Times New Roman",serif'>Chemotherapy medicine</span></u></b></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Tell your doctor immediately </span></b><span style='font-family:"Times New Roman",serif'>if you get any of the following side effects after receiving chemotherapy medicine. They usually happen within the first few days and several weeks after receiving chemotherapy medicine, but can also develop much later.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Very common </span></b><span style='font-family:"Times New Roman",serif'>(may affect more than 1 in 10 people)</span></p><p class="MsoListParagraphCxSpFirst" style="margin-top:0in;margin-right:-1.45pt; margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>Pain in the right upper abdomen under the ribs, yellowing of eyes or skin, rapid weight gain, swelling of arms, legs and abdomen, and trouble breathing. These may be signs of a serious liver condition called veno-occlusive disease.</span></p><p class="MsoListParagraphCxSpLast" style="margin-top:0in;margin-right:-1.45pt; margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>Prolonged bleeding or bleeding without injury such as nosebleeds, bleeding from gums, or vaginal bleeding.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Other possible side effects</span></b></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Tell your doctor immediately if side effects become severe or serious.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Very common side effects </span></b><span style='font-family:"Times New Roman",serif'>(may affect more than 1 in 10 people)</span></p><ul style="margin-top:0in" type="disc"> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><a name="_Hlk543255"><span style='font-family:"Times New Roman",serif'>low      level of red and white blood cells, sometimes with a fever</span></a></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>increase of      certain enzymes in the blood which may indicate a problem with your liver</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>a low level of      blood platelets, which may reduce the ability of blood to clot</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>unusual hair      loss or thinning</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>stomach pain, constipation,      diarrhoea</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>feeling sick      (nausea), being sick (vomiting)</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>fever</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>soreness of the      mouth</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>inflammation of      the throat</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>dark patches on      skin</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>soreness of the      rectum area</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>trouble sleeping</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>decreased      appetite</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>headache</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>tiredness</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>itchy skin</span></li> </ul><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><a name="_Hlk543255"><span style='font-family:"Times New Roman",serif'>low      level of red and white blood cells, sometimes with a fever</span></a></li><a name="_Hlk543255"><span style='font-family:"Times New Roman",serif'>low      level of red and white blood cells, sometimes with a fever</span></a><span style='font-family:"Times New Roman",serif'>low      level of red and white blood cells, sometimes with a fever</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>increase of      certain enzymes in the blood which may indicate a problem with your liver</span></li><span style='font-family:"Times New Roman",serif'>increase of      certain enzymes in the blood which may indicate a problem with your liver</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>a low level of      blood platelets, which may reduce the ability of blood to clot</span></li><span style='font-family:"Times New Roman",serif'>a low level of      blood platelets, which may reduce the ability of blood to clot</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>unusual hair      loss or thinning</span></li><span style='font-family:"Times New Roman",serif'>unusual hair      loss or thinning</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>stomach pain, constipation,      diarrhoea</span></li><span style='font-family:"Times New Roman",serif'>stomach pain, constipation,      diarrhoea</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>feeling sick      (nausea), being sick (vomiting)</span></li><span style='font-family:"Times New Roman",serif'>feeling sick      (nausea), being sick (vomiting)</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>fever</span></li><span style='font-family:"Times New Roman",serif'>fever</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>soreness of the      mouth</span></li><span style='font-family:"Times New Roman",serif'>soreness of the      mouth</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>inflammation of      the throat</span></li><span style='font-family:"Times New Roman",serif'>inflammation of      the throat</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>dark patches on      skin</span></li><span style='font-family:"Times New Roman",serif'>dark patches on      skin</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>soreness of the      rectum area</span></li><span style='font-family:"Times New Roman",serif'>soreness of the      rectum area</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>trouble sleeping</span></li><span style='font-family:"Times New Roman",serif'>trouble sleeping</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>decreased      appetite</span></li><span style='font-family:"Times New Roman",serif'>decreased      appetite</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>headache</span></li><span style='font-family:"Times New Roman",serif'>headache</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>tiredness</span></li><span style='font-family:"Times New Roman",serif'>tiredness</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>itchy skin</span></li><span style='font-family:"Times New Roman",serif'>itchy skin</span><p class="MsoListParagraph" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>soreness and swelling of the digestive tract lining which runs from the mouth to the anus</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:.5in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Common side effects </span></b><span style='font-family:"Times New Roman",serif'>(may affect up to 1 in 10 people)</span></p><p class="MsoListParagraphCxSpFirst" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>life-threatening inflammatory response to an infection along with low white blood cell count</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>heart failure</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>infections which may make you feel warm, chilly, or sweaty</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>mass in the lungs</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>enlarged abdomen</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>enlarged liver</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>difficulty breathing </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>abdominal pain</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>bleeding or bruising </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>blood in urine</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>yellowing of eyes or skin</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>small tear in tissue that lines the anus</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>dizziness, or sensation of feeling off balance or like the room is spinning</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>memory problems </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>anxiety </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>positive test for Aspergillus (lung disease caused by fungus)</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>changes and abnormalities in heart rhythm</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>pain, including in back, bone, skin, limbs, anus, or muscles</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>vaginal yeast infection</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>heartburn</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>inflammation of the gallbladder</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>gallstones</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>cough</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>abnormal sense of taste or loss of taste</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>difficulty swallowing</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>swelling of the face</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>feeling cold</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>excess water in the body</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>inflammation or infection of hair follicles</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>decrease in speed of air leaving your lungs</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>stomach discomfort with nausea and vomiting</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>inflammation in the digestive tract</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>gum disease</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>piles (haemorrhoids)</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>hiccups</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>low blood pressure</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>low body temperature</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>low oxygen level in blood</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>pain in mouth, throat or larynx (voice box)</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>lack of energy</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>irregular menstruation</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>loss of function or decreased function of your ovaries or testes</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>premature menopause </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>spots on skin from bleeding under the skin</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>skin that is discoloured, blotchy, or darker or lighter than normal </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>fluid in or around the lung</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>hot flush</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>increased frequency of urination</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>dry, itchy skin </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>dry lips</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>rash sometimes with lesions or pus </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>inflamed skin lesions</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>skin abrasion/scrape</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>sweat gland disorder</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>transfusion reaction</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>weight decreased</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>abnormal liver tests</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>increased concentration of haemoglobin in cells</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span lang="DE" style="font-family:Symbol"></span><span lang="DE" style='font-family:"Times New Roman",serif'>changes in magnesium, calcium, potassium, phosphate, albumin, protein, sodium in blood</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span lang="EN-GB" style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>increase in blood test for inflammation</span></p><p class="MsoListParagraph" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>excess acid in the body not removed by the kidneys</span></p><p class="MsoListParagraph" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>increase or decrease in white blood cells</span></p><p class="MsoListParagraph" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>low number of immature (not fully developed) red blood cells </span></p><p class="MsoListParagraph" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>increase in female hormones</span></p><p class="MsoListParagraph" style="margin-bottom:0in;text-indent:-.25in; line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>decreased testosterone</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><b><u><span style='font-family:"Times New Roman",serif'></span></u></b></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal;page-break-after:avoid"><b><u><span style='font-family:"Times New Roman",serif'>Zynteglo</span></u></b></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Most side effects occur during or within a few days after treatment with Zynteglo but can occur later. </span><span style='font-family:"Times New Roman",serif'>Tell your doctor immediately if side effects become severe or serious.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Very common side effects </span></b><span style='font-family:"Times New Roman",serif'>(may affect more than 1 in 10 people)</span></p><p class="MsoListParagraph" style="margin-top:0in;margin-right:-1.45pt; margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>stomach pain</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Common side effects </span></b><span style='font-family:"Times New Roman",serif'>(may affect up to 1 in 10 people)</span></p><ul style="margin-top:0in" type="disc"> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>low level of      blood platelets, which may reduce the ability of blood to clot</span></li> <li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>low level of      white blood cells</span></li> </ul><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>low level of      blood platelets, which may reduce the ability of blood to clot</span></li><span style='font-family:"Times New Roman",serif'>low level of      blood platelets, which may reduce the ability of blood to clot</span><li class="MsoNormal" style="margin-right:-1.45pt;margin-bottom:0in;line-height:      normal"><span style='font-family:"Times New Roman",serif'>low level of      white blood cells</span></li><span style='font-family:"Times New Roman",serif'>low level of      white blood cells</span><p class="MsoListParagraph" style="margin-top:0in;margin-right:-1.45pt; margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>shortness of breath</span></p><p class="MsoListParagraph" style="margin-top:0in;margin-right:-1.45pt; margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>chest pain not due to a heart problem</span></p><p class="MsoListParagraph" style="margin-top:0in;margin-right:-1.45pt; margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>flushing (redness and warmth of skin)</span></p><p class="MsoListParagraph" style="margin-top:0in;margin-right:-1.45pt; margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal"><span style="font-family:Symbol"></span><span style='font-family:"Times New Roman",serif'>pain in legs</span></p><p class="MsoListParagraph" style="margin-top:0in;margin-right:-1.45pt; margin-bottom:0in;margin-left:.5in;line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Reporting of side effects"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via <span style="background:lightgrey">the national reporting system listed in </span></span><a href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span style='font-family:"Times New Roman",serif;background:lightgrey'>Appendix V</span></a><span style='font-family:"Times New Roman",serif;background:lightgrey'>.</span><span style='font-family:"Times New Roman",serif'> By reporting side effects you can help provide more information on the safety of this medicine.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.45pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="5.       How to store Zynteglo"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>This information is intended for doctors only.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>As this medicine will be given by a qualified doctor, they are responsible for the correct storage of the medicine before and during its use, as well as for its correct disposal. </span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Keep this medicine out of the sight and reach of children. </span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Do not use this medicine after the expiry date which is stated on the outer container label(s) and infusion bag label(s).</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Store at -140C for up to a year. Do not thaw the product until it is ready to be used. Once thawed store at room temperature (20C25C) and use within 4 hours.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>This medicine contains genetically-modified cells. Unused medicine must be disposed of in compliance with the local guidelines on handling human-derived material. </span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="6.       Contents of the pack and other information"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="What Zynteglo contains "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:.25in;text-indent:-.25in;line-height:normal"><span style='font-family:"Times New Roman",serif'>-</span><span style='font-family:"Times New Roman",serif'>The active substance of Zynteglo consists of your own blood stem cells that contain functional copies of the beta-globin gene that can be measured in your blood. The concentration is 1.220  10<sup>6</sup> CD34<sup>+</sup> cells (blood stem cells) per millilitre.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:.25in;text-indent:-.25in;line-height:normal"><span style='font-family:"Times New Roman",serif'>-</span><span style='font-family:"Times New Roman",serif'>The other ingredients are a solution used to preserve frozen cells and sodium chloride. See section 2, Sodium content.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="What Zynteglo looks like and contents of the pack"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><a name="_Hlk511315491"><span style='font-family:"Times New Roman",serif'>Zynteglo is a clear to slightly cloudy, colourless to yellow or pink dispersion of cells</span></a><span style='font-family:"Times New Roman",serif'> that is supplied in one or more clear infusion bags, each packed in a transparent pouch inside a closed metal container. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Your name and date of birth, as well as coded information identifying you as the patient, are printed onto each infusion bag and each metal container.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Marketing Authorisation Holder and Manufacturer"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>bluebird bio (Netherlands) B.V. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span lang="NL" style='font-family:"Times New Roman",serif'>Stadsplateau 7 </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span lang="NL" style='font-family:"Times New Roman",serif'>WTC Utrecht </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span lang="NL" style='font-family:"Times New Roman",serif'>3521AZ Utrecht </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span lang="NL" style='font-family:"Times New Roman",serif'>The Netherlands </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><a href="mailto:medinfo@bluebirdbio.com"><span lang="PT" style='font-family:"Times New Roman",serif'>medinfo@bluebirdbio.com</span></a></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><b><span lang="PT" style='font-family:"Times New Roman",serif'>Manufacturer</span></b></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span lang="PT" style='font-family:"Times New Roman",serif'>Minaris Regenerative Medicine GmbH </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Haidgraben 5</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>85521 Ottobrunn</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Germany</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:-1.7pt;border-collapse:collapse" width="624"> <tr> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><a name="_Hlk1050692"><b><span lang="DE" style='font-family:"Times New Roman",serif'>Deutschland</span></b></a></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span lang="DE" style='font-family:"Times New Roman",serif'>bluebird bio (Germany)   GmbH</span></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span lang="DE" style='font-family:"Times New Roman",serif'>Tel: +49 (0) 893 803 7456   (0800 181 0702)</span></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><b><span lang="ES" style='font-family:"Times New Roman",serif'>Italia</span></b></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span lang="ES" style='font-family:"Times New Roman",serif'>bluebird bio (Italy)   S.r.l.</span></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span lang="DE" style='font-family:"Times New Roman",serif'>Tel: </span><span style='font-family:"Times New Roman",serif'>+39 029 475 9755 (800 728 026)</span></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p> </td> </tr> <tr> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>France</span></b></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>bluebird bio (France) SAS</span></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal;text-autospace:   none"><span style='font-family:"Times New Roman",serif'>Tl: +33 (0)1 85 14   97 89 (0800 914 510)</span></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal;text-autospace:   none"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><b><span lang="NL" style='font-family:"Times New Roman",serif'>Nederland</span></b></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span lang="NL" style='font-family:"Times New Roman",serif'>bluebird bio   (Netherlands) B.V.</span></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Tel: +</span><span lang="DE" style='font-family:"Times New Roman",serif'>31 (0) 303 100 450</span></p> </td> </tr> <tr> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>Belgi/Belgique/Belgien,   , esk   republika, Danmark, Eesti, , Espaa, </span></b><b><span style='font-family:"Times New Roman",serif'>Hrvatska, Ireland, sland,   , Latvija, Lietuva, Luxembourg/Luxemburg,   Magyarorszg, Malta, Norge, sterreich, Polska, Portugal, Romnia, Slovenija,   Slovensk republika, Suomi/Finland, Sverige</span></b></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>bluebird bio (Netherlands) B.V.</span></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Tl/Tel/Te/Tlf//Smi/Puh:   </span></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>+31 (0) </span><span lang="DE" style='font-family:"Times New Roman",serif'>303 100 450</span></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><a href="mailto:medinfo@bluebirdbio.com"><span lang="DE" style='font-family:"Times New Roman",serif'>medinfo@bluebirdbio.com</span></a></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>United Kingdom</span></b></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>bluebird bio (UK) Limited</span></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Tel: +44 (0) 207 660 0754</span></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'> (0800-069-8046)</span></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p> <p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p> </td> </tr> </table><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><b><span style='font-family:"Times New Roman",serif'>This leaflet was last revised in &lt;</span></b><span style='font-family:"Times New Roman",serif'>{<b>MM/YYYY</b>}&gt;</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>This medicine has been given conditional approval. This means that there is more evidence to come about this medicine. </span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>The European Medicines Agency will review new information on this medicine at least every year and this leaflet will be updated as necessary.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span lang="EN-GB" style='font-family:"Times New Roman",serif'>Detailed information on this medicine is available on the European Medicines Agency web site: </span><u><span lang="EN-GB" style='font-family:"Times New Roman",serif; color:blue'>http://www.ema.europa.eu</span></u><span lang="EN-GB" style='font-family:"Times New Roman",serif'>&lt;, and on the website of {name of MS Agency (link)}&gt;.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>This leaflet is available in all EU/EEA languages on the European Medicines Agency website.</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>-----------------------------------------------------------------------------------------------------------------</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-1.4pt;margin-bottom: 0in;margin-left:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="The following information is intended for healthcare professionals only: "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-top:0in;margin-right:-1.4pt;margin-bottom: 0in;margin-left:-2.0pt;line-height:normal;page-break-after:avoid"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Zynteglo is shipped from the manufacturing facility to the infusion centre storage facility in a cryoshipper, which may contain multiple metal cassettes intended for a single patient. Each metal cassette contains one infusion bag with Zynteglo. A patient may have multiple infusion bags. The infusion bag(s) must be kept inside the metal cassette(s) until ready to thaw and use.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Confirm that Zynteglo is printed on the infusion bag(s). Confirm that patient identity matches the unique patient information located on the infusion bag(s) and metal cassette(s) prior to infusion.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Account for all infusion bags and confirm each infusion bag of Zynteglo is within the expiry date using the accompanying Lot Information Sheet. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Inspect each infusion bag for any breaches of integrity before thawing and infusion. If an infusion bag is compromised, follow the local guidelines on handling human-derived material and contact bluebird bio immediately.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Zynteglo is intended solely for autologous use. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>After carefully removing the outer metal container, thaw each infusion bag at 37C in a water bath or dry bath for approximately 24 minutes. Do not overthaw the medicinal product. Do not leave the medicinal product unattended and do not submerge the infusion ports if thawed in a water bath. After thaw, mix the medicinal product gently by massaging the infusion bag until all of the contents are uniform. Expose the sterile port on the infusion bag by tearing off the protective wrap covering the port. Access the infusion bag and infuse per the administration sites standard procedures for administration of cell therapy products. Do not use an in-line blood filter or an infusion pump. Do not sample, alter, or irradiate the medicinal product. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Administer each infusion bag via intravenous infusion over a period of less than 30 minutes. If more than one infusion bag is provided, administer each infusion bag completely before proceeding to thaw and infuse the next bag. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Zynteglo must not be refrozen. Infuse as soon as possible and no more than 4 hours after thawing. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Flush all Zynteglo remaining in the infusion bag and any associated tubing with at least 50 mL of 0.9% sodium chloride solution to ensure as many cells as possible are infused into the patient.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>This medicinal product contains genetically-modified cells. Local guidelines on handling and waste of human-derived material applicable for such products should be followed.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Healthcare professionals handling Zynteglo should take standard precautions (wearing gloves, protective clothing and eye protection) to avoid potential transmission of infectious diseases.</span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"><span style='font-family:"Times New Roman",serif'>Work surfaces and material which have potentially been in contact with Zynteglo must be decontaminated with a viricidal disinfectant according to the manufacturer's instructions. </span></p><p class="MsoNormal" style="margin-bottom:0in;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
	
</section>
							<!-- sections can repeat as necessary -->
						</Composition>
					</resource>
				</entry>
				
			</Bundle>
		</resource>
	</entry>
</Bundle>